1. Sei-1 promotes double minute chromosomes formation through activation of the PI3K/Akt/BRCA1-Abraxas pathway and induces double-strand breaks in NIH-3T3 fibroblasts
   Xing Tian et al, 2018, Cell Death & Disease CrossRef
2. Exploring the Role of TRIP-Brs in Human Breast Cancer: An Investigation of Expression, Clinicopathological Significance, and Prognosis
   Raj Kumar Mongre et al, 2020, Molecular Therapy - Oncolytics CrossRef
3. Internalization of Foldamer-Based DNA Mimics through a Site-Specific Antibody Conjugate to Target HER2-Positive Cancer Cells
   Valentina Corvaglia et al, 2021, Pharmaceuticals CrossRef
4. HER2 Antibody–Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor
   Tom Zhang et al, 2024, Clinical Cancer Research CrossRef
5. SERTAD1 initiates NLRP3-mediated inflammasome activation through restricting NLRP3 polyubiquitination
   Jihoon Ha et al, 2024, Cell Reports CrossRef
6. Nutrient/serum starvation derived TRIP-Br3 down-regulation accelerates apoptosis by destabilizing XIAP
   Chengping Li et al, 2015, Oncotarget CrossRef
7. Inhibitory role of TRIP-Br1 oncoprotein in hypoxia-induced apoptosis in breast cancer cell lines
   CHENGPING LI et al, 2016, International Journal of Oncology CrossRef
8. SERTAD1 Sensitizes Breast Cancer Cells to Doxorubicin and Promotes Lysosomal Protein Biosynthesis
   Hai Anh Nguyen et al, 2022, Biomedicines CrossRef
9. TRIP-Br1 oncoprotein inhibits autophagy, apoptosis, and necroptosis under nutrient/serum-deprived condition
   Samil Jung et al, 2015, Oncotarget CrossRef